Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and we’ll share relevant market report titles for you to explore.
- Drugs and Treatments for Autoimmune Diseases: Global Markets
Report SummaryREASONS FOR DOING THE STUDYThe objective of this study is to provide an in-depth analysis and forecast of the global autoimmune products market.The focus is on products and therapies cu...
- Hot Topics in Type 2 Diabetes: Physician Perceptions of Incretin Mimetics and TZDs ¬– Physician survey provides insights into TZD, DPP-IV, and GLP-1 usage
IntroductionPrescribing practices for the key branded non-insulin classes - TZDs, DPP-IV inhibitors, and GLP-1 agonists - vary widely among the seven major markets. Datamonitor surveyed 199 primary c...
- Stakeholder Opinions: Hepatocellular cancer
IntroductionDespite the approval of Nexavar (sorafenib; Onyx pharmaceuticals/Bayer), patient outcomes remain poor. The large patient population and the lack of effective agents are driving R&D interest. The majority of pipel...
- Next Generation Energy Food and Drinks: Success strategies for consumer targeting, natural and sustained release energy
The need of the consumer for an ever-greater ability to work and play is increasing the demand for an energy fix in the form of foods and beverages. However, with work stress and fatigue increasing and the dem...
- Stakeholder Opinions: Sexually Transmitted Diseases - An underestimated threat lacking interventions to prevent transmission
IntroductionSexually transmitted diseases (STDs) represent a significant health threat given their potentially serious complications and association with increased transmission of human immunodeficiency virus (HIV). High di...
- Stakeholder Opinions: Ovarian Cancer - Approaching the era of molecular targeted therapy
IntroductionDespite advances in the management of the disease, outcomes remain poor for patients with advanced epithelial ovarian cancer. The high level of unmet need, coupled with the large size of the patient population, ...
- Stakeholder Insight: Cancer Pain - Physician survey highlights inadequacies in education and treatment
IntroductionEstimated to affect 6.7 million individuals across the seven major markets in 2009, the population of patients suffering from cancer pain is expected to increase in the future as elderly and minority populations...
- Stakeholder Opinions: Celiac Disease - Licensing opportunities exist in untapped market
IntroductionLow disease awareness, poor diagnosis rates, combined with a lack of pharmaceutical industry involvement, has kept celiac disease from the limelight. However, this is changing as evidenced by Shire's recent involvement in...
- Stakeholder Insight: Psoriasis - Biologics are yet to make topical treatments obsolete
IntroductionPatient perception of disease severity drives treatment-seeking behavior in psoriasis. New therapeutic options targeting specific mechanisms are set to reshape severe psoriasis therapy. However, current biologics have not...